Arno Therapeutics
Flemington, US · Delaware corporation
Founders & leadership
SP
Stefan Proniuk, Ph.D.Executive
AZ
Alexander Zukiwski, M.D.Executive
Board
JM
Jay MoorinBoard director
TK
Tomer KarivBoard director
SB
Steven B. RuchefskyBoard director
DM
David M. TanenBoard director
YR
Yacov ReizmanBoard director
WF
William F. Hamilton, Ph.D.Board director
AS
Arie S. Belldegrun, M.D.Board director
Reported raises · per SEC filings
Form D private placements$4.5M disclosed across 1 round · 2016
▶$4.5MraisedAug 2016 · 15 investors · PharmaceuticalsRule 506(b)
▶$4.5MraisedAug 2016 · 15 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jay MoorinDirector
- Tomer KarivDirector
- Steven B. RuchefskyDirector
- David M. TanenDirector
- Yacov ReizmanDirector
- William F. Hamilton, Ph.D.Director
- Stefan Proniuk, Ph.D.Executive Officer
- Arie S. Belldegrun, M.D.Director
- Alexander Zukiwski, M.D.Executive Officer, Director
- Offering amount
- $4.5M
- Amount sold
- $4.5M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Arno Therapeutics raised?
- Arno Therapeutics has disclosed $4.5M raised across 1 round.
- Where is Arno Therapeutics headquartered?
- Arno Therapeutics is headquartered in Flemington, US.